Concepedia

Publication | Open Access

Acquired Lipodystrophy Associated With Nivolumab in a Patient With Advanced Renal Cell Carcinoma

52

Citations

3

References

2019

Year

Abstract

Anti-PD1 therapy has great potential. Early recognition of the onset of unusual collateral effects is important to improve decision making regarding the treatment of patients with tumors.

References

YearCitations

Page 1